{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:58:40Z","timestamp":1790225920554,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T00:00:00Z","timestamp":1561507200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T00:00:00Z","timestamp":1561507200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s00280-019-03901-7","type":"journal-article","created":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T18:12:20Z","timestamp":1561572740000},"page":"345-350","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Oxaliplatin induces prostaglandin E2 release in vascular endothelial cells"],"prefix":"10.1007","volume":"84","author":[{"given":"Satoru","family":"Matsunuma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoko","family":"Handa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Kamei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitomi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"Okuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhisa","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,26]]},"reference":[{"key":"3901_CR1","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1200\/JCO.2007.14.9898","volume":"26","author":"J Cassidy","year":"2008","unstructured":"Cassidy J, Clarke S, D\u00edaz-Rubio E et al (2008) Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil\/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer. J Clin Oncol 26:2006\u20132012","journal-title":"J Clin Oncol"},{"key":"3901_CR2","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/S1470-2045(13)70490-X","volume":"14","author":"Y Yamada","year":"2013","unstructured":"Yamada Y, Takahari D, Matsumoto H et al (2013) Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trial. Lancet Oncol 14:1278\u20131286","journal-title":"Lancet Oncol"},{"key":"3901_CR3","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1007\/s10120-016-0606-4","volume":"20","author":"N Fuse","year":"2017","unstructured":"Fuse N, Bando H, Chin K et al (2017) Adjuvant capecitabine plus oxaliplatin after D2 gastrectomy in Japanese patients with gastric cancer: a phase II study. Gastric Cancer 20:332\u2013340","journal-title":"Gastric Cancer"},{"key":"3901_CR4","doi-asserted-by":"publisher","first-page":"177","DOI":"10.5649\/jjphcs.38.177","volume":"38","author":"Y Suga","year":"2012","unstructured":"Suga Y, Sakaguchi Y, Ishizaki J et al (2012) Investigation for risk factor and preventive effect of NSAIDs, opioid on gemcitabine-induced vascular pain. Jpn J Pharm Heal Care Sci 38:177\u2013183","journal-title":"Jpn J Pharm Heal Care Sci"},{"key":"3901_CR5","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1093\/jjco\/hyh029","volume":"34","author":"K Yoh","year":"2004","unstructured":"Yoh K, Niho S, Goto K (2004) High body mass index correlates with increased risk of venous irritation by vinorelbine infusion. Jpn J Clin Oncol 34:206\u2013209","journal-title":"Jpn J Clin Oncol"},{"key":"3901_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3999\/jscpt.32.15","volume":"32","author":"M Kawahara","year":"2001","unstructured":"Kawahara M, Ishida T, Emoto C et al (2001) Determination of a pain substance produced by the photodegradation of dacarbazine. Jpn J Clin Pharmacol Ther 32:15\u201322","journal-title":"Jpn J Clin Pharmacol Ther"},{"key":"3901_CR7","first-page":"93","volume":"36","author":"Y Suga","year":"2009","unstructured":"Suga Y, Kumazaki M, Nishigami J et al (2009) Improvement of epirubicin-induced phlebitis to switch from liquid preparation to lyophilized formulation. Gan Kagaku Ryoho 36:93\u201396","journal-title":"Gan Kagaku Ryoho"},{"key":"3901_CR8","first-page":"801","volume":"44","author":"M Hino","year":"2008","unstructured":"Hino M, Haruta K, Yoshimura T et al (2008) Evaluation and measurement of vascular pain developing during administration of gemcitabine hydrochloride. J Jpn Soc Hosp Pharm 44:801\u2013803","journal-title":"J Jpn Soc Hosp Pharm"},{"key":"3901_CR9","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.lungcan.2006.10.016","volume":"55","author":"K Yoh","year":"2007","unstructured":"Yoh K, Niho S, Goto K et al (2007) Randomized trial of drip infusion versus bolus injection of vinorelbine for the control of local venous toxicity. Lung Cancer 55:337\u2013341","journal-title":"Lung Cancer"},{"key":"3901_CR10","first-page":"680","volume":"36","author":"M Onogawa","year":"2010","unstructured":"Onogawa M, Ogawa K, Miyamura M (2010) Improvement of injection procedure for epirubicin hydrochloride to reduce venous pain. Jpn J Clin Pharmacol Ther 36:680\u2013683","journal-title":"Jpn J Clin Pharmacol Ther"},{"key":"3901_CR11","first-page":"381","volume":"39","author":"K Morio","year":"2013","unstructured":"Morio K, Tsugane M, Okamoto Y et al (2013) Effectiveness of a newly designed shield to prevent the photodegradation of dacarbazine. Jpn J Clin Pharmacol Ther 39:381\u2013387","journal-title":"Jpn J Clin Pharmacol Ther"},{"key":"3901_CR12","first-page":"985","volume":"43","author":"S Handa","year":"2016","unstructured":"Handa S, Kuroiwa R, Miyano M et al (2016) Assessment of injection site reactions for peripheral intravenous oxaliplatin infusion and potential remedies. Gan Kagaku Ryoho 43:985\u2013988","journal-title":"Gan Kagaku Ryoho"},{"key":"3901_CR13","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.clcc.2015.11.004","volume":"15","author":"A Lapeyre-Prost","year":"2016","unstructured":"Lapeyre-Prost A, Hug de Larauze MH, Chibaudel B et al (2016) Feasibility of capecitabine and oxaliplatin combination chemotherapy without central venous access device in patients with stage III colorectal cancer. Clin Colorectal Cancer 15:250\u2013256","journal-title":"Clin Colorectal Cancer"},{"key":"3901_CR14","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1161\/ATVBAHA.110.207449","volume":"31","author":"E Ricciotti","year":"2011","unstructured":"Ricciotti E, FitzGerald GA (2011) Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol 31:986\u20131000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3901_CR15","first-page":"36","volume":"313","author":"H Kawaguchi","year":"1995","unstructured":"Kawaguchi H, Pilbeam CC, Harrison JR et al (1995) The role of prostaglandins in the regulation of bone metabolism. Clin Orthop Relat Res 313:36\u201346","journal-title":"Clin Orthop Relat Res"},{"key":"3901_CR16","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1136\/gut.2004.047100","volume":"55","author":"D Wang","year":"2006","unstructured":"Wang D, Dubois RN (2006) Prostaglandins and cancer. Gut 55:115\u2013122","journal-title":"Gut"},{"key":"3901_CR17","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1152\/physrev.00004.2008","volume":"88","author":"JL Wallace","year":"2008","unstructured":"Wallace JL (2008) Prostaglandins, NSAIDs, and gastric mucosal protection: why doesn\u2019t the stomach digest itself? Physiol Rev 88:1547\u20131565","journal-title":"Physiol Rev"},{"key":"3901_CR18","doi-asserted-by":"publisher","first-page":"32783","DOI":"10.1074\/jbc.M003505200","volume":"275","author":"M Murakami","year":"2000","unstructured":"Murakami M, Naraba H, Tanioka T et al (2000) Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2. J Biol Chem 275:32783\u201332792","journal-title":"J Biol Chem"},{"key":"3901_CR19","doi-asserted-by":"publisher","first-page":"37937","DOI":"10.1074\/jbc.M305108200","volume":"278","author":"M Murakami","year":"2003","unstructured":"Murakami M, Nakashima K, Kamei D et al (2003) Cellular prostaglandin E2 production by membrane-bound prostaglandin E synthase-2 via both cyclooxygenases-1 and -2. J Biol Chem 278:37937\u201337947","journal-title":"J Biol Chem"},{"key":"3901_CR20","doi-asserted-by":"publisher","first-page":"10272","DOI":"10.1073\/pnas.180319297","volume":"97","author":"LR Ballou","year":"2000","unstructured":"Ballou LR, Botting RM, Goorha S, Zhang J, Vane JR (2000) Nociception in cyclooxygenase isozyme-deficient mice. Proc Natl Acad Sci USA 97:10272\u201310276","journal-title":"Proc Natl Acad Sci USA"},{"key":"3901_CR21","doi-asserted-by":"publisher","first-page":"33684","DOI":"10.1074\/jbc.M400199200","volume":"279","author":"D Kamei","year":"2004","unstructured":"Kamei D, Yamakawa K, Takegoshi Y et al (2004) Reduced pain hypersensitivity and inflammation in mice lacking microsomal prostaglandin E synthase-1. J Biol Chem 279:33684\u201333695","journal-title":"J Biol Chem"},{"key":"3901_CR22","first-page":"55","volume":"8","author":"M Zhao","year":"2012","unstructured":"Zhao M, Isami K, Nakamura S, Shirakawa H, Nakagawa T, Kaneko S (2012) Acute cold hypersensitivity characteristically induced by oxaliplatin is caused by the enhanced responsiveness of TRPA1 in mice. Mol Pain 8:55","journal-title":"Mol Pain"},{"key":"3901_CR23","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1124\/mol.107.040832","volume":"73","author":"TE Taylor-Clark","year":"2008","unstructured":"Taylor-Clark TE, Undem BJ, Macglashan DW, Ghatta S, Carr MJ, McAlexander MA (2008) Prostaglandin-induced activation of nociceptive neurons via direct interaction with transient receptor potential A1 (TRPA1). Mol Pharmacol 73:274\u2013281","journal-title":"Mol Pharmacol"},{"issue":"1973","key":"3901_CR24","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/j.1476-5381.1997.tb06823.x","volume":"120","author":"SH Ferreira","year":"1997","unstructured":"Ferreira SH, Moncada S, Vane JR (1997) Prostaglandins and the mechanism of analgesia produced by aspirin-like drugs. Br J Pharmacol 120(1973):401\u2013412 (discussion 399\u2013400)","journal-title":"Br J Pharmacol"},{"key":"3901_CR25","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/0006-8993(89)90928-1","volume":"492","author":"YO Taiwo","year":"1989","unstructured":"Taiwo YO, Levine JD (1989) Prostaglandin effects after elimination of indirect hyperalgesic mechanisms in the skin of the rat. Brain Res 492:397\u2013399","journal-title":"Brain Res"},{"key":"3901_CR26","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1152\/physrev.1999.79.4.1193","volume":"79","author":"S Narumiya","year":"1999","unstructured":"Narumiya S, Sugimoto Y, Ushikubi F (1999) Prostanoid receptors: structures, properties, and functions. Physiol Rev 79:1193\u20131226","journal-title":"Physiol Rev"},{"key":"3901_CR27","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1093\/bja\/aei184","volume":"95","author":"R Ando","year":"2005","unstructured":"Ando R, Watanabe C (2005) Characteristics of propofol-evoked vascular pain in anaesthetized rats. Br J Anaesth 95:384\u2013392","journal-title":"Br J Anaesth"},{"key":"3901_CR28","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1124\/pr.56.3.3","volume":"56","author":"DL Simmons","year":"2004","unstructured":"Simmons DL, Botting RM, Hla T (2004) Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol Rev 56:387\u2013437","journal-title":"Pharmacol Rev"},{"key":"3901_CR29","doi-asserted-by":"publisher","first-page":"32775","DOI":"10.1074\/jbc.M003504200","volume":"275","author":"T Tanioka","year":"2000","unstructured":"Tanioka T, Nakatani Y, Semmyo N, Murakami M, Kudo I (2000) Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis. J Biol Chem 275:32775\u201332782","journal-title":"J Biol Chem"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-019-03901-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-019-03901-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-019-03901-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T23:11:02Z","timestamp":1593040262000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-019-03901-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,26]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["3901"],"URL":"https:\/\/doi.org\/10.1007\/s00280-019-03901-7","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,26]]},"assertion":[{"value":"20 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}}]}}